InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Buck Kristen K, Directeur R&D et Marketing. Director active across 2 companies, notably Caladrius Biosciences, INC.. Aggregated, 13 disclosures have been logged. Activity tracked since 1 September 2021. The latest transaction was filed on 9 January 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 条申报中的 13 条
Buck Kristen K is Director R&D and Marketing. She has 13 filings in total, and across the 13 most recent filings available, the recorded amounts are EUR 0 in buys and EUR 0 in sells, with filings ranging from 2021-09-03 to 2026-01-13. The most common transaction nature is Attribution, and the companies mentioned are LISATA THERAPEUTICS, INC. and Caladrius Biosciences, INC.